Profil
In addition to his role with Vesalius Ventures, Dr. KenKnight is Vice President of Research and New Business Development for Boston Scientific, Cardiac Rhythm Management Division and Adjunct Professor of Biomedical Engineering at the University of Minnesota.
Since joining Boston Scientific, CRM (previously known as Guidant) in 1990, Dr. KenKnight held various technical and managerial roles, including Senior Principal Scientist, Visiting Scientist, Basic Arrhythmia Lab, Duke University, Visiting Principal Scientist, Cardiac Rhythm Management Lab, University of Alabama at Birmingham, and Manager of Tachycardia & Bradycardia Therapy Research.
He was promoted to Director of Heart Failure, Atrial Arrhythmia and Emerging Technology Research in 1999.
Prior to joining Guidant he worked in various research and development roles with early-stage medical technology companies.
He is an author of 45 peer-reviewed manuscripts, reviews and book chapters as well as nearly 100 conference abstracts in fields relating to cardiac electrophysiology and heart failure.
He is an editorial consultant for the Journal of Cardiovascular Electrophysiology, Heart Rhythm, Cardiovascular Research and the International Journal of Cardiology.Since founding the business development function at Guidant, Dr. KenKnight has led the execution of numerous transactions including private equity investments in early-stage technology companies, strategic alliances, as well as, in-licensing and out-licensing of critical technologies.
A native of Minnesota, Dr. KenKnight received his bachelor of science degree in mechanical engineering, master of science and Ph.D.
degrees in biomedical engineering from the Institute of Technology at the University of Minnesota in Minneapolis.
Postes actifs de Bruce H. KenKnight
| Sociétés | Poste | Début |
|---|---|---|
| CYBERONICS, INC. | Corporate Officer/Principal | 01/01/2013 |
Vesalius Ventures, Inc
Vesalius Ventures, Inc Investment ManagersFinance Vesalius Ventures invests in companies located in the United States. The firm targets companies operating in the fields of telemedicine, medical technology, telecommunications and information technologies will be utilized for the delivery of healthcare. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de Bruce H. KenKnight
| Sociétés | Poste | Fin |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/01/2010 |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Corporate Officer/Principal | 01/01/2010 |
Valtech Cardio Ltd.
Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Develops devices for mitral valve repair and replacement | President | - |
CardioNet LLC
CardioNet LLC Medical SpecialtiesHealth Technology Provides cardiac monitoring services | Directeur Technique/Scientifique/R&D | - |
Formation de Bruce H. KenKnight
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
LivaNova USA, Inc.
LivaNova USA, Inc. Medical SpecialtiesHealth Technology Engages in design, development, sale and marketing of implantable medical devices | Health Technology |
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
CardioNet LLC
CardioNet LLC Medical SpecialtiesHealth Technology Provides cardiac monitoring services | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vesalius Ventures, Inc
Vesalius Ventures, Inc Investment ManagersFinance Vesalius Ventures invests in companies located in the United States. The firm targets companies operating in the fields of telemedicine, medical technology, telecommunications and information technologies will be utilized for the delivery of healthcare. It provides financing for early stage capital requirements. | Finance |
Valtech Cardio Ltd.
Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Develops devices for mitral valve repair and replacement | Health Technology |
















